This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • Genomic Biomarker Testing
      • PEACE-3 Trial
      • PROfound Trial
      • PSMAfore Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
      • CAPItello-281 Trial
      • PSMAddition Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
      • BOND-003 Cohort P
      • CORE-001 Study
      • CORE-008
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Daniel D. Joyce, MD, MS
        • Bladder Cancer
          • Non-Muscle Invasive Bladder Cancer
            Ashish Kamat, MD
          • Muscle-Invasive Bladder Cancer
          • Advanced & Metastatic Bladder Cancer (mUC)
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Biochemical Recurrence in Prostate Cancer
        • Decipher® Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • mCRPC with Bone Metastasis
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
        • Radioligand Therapy
          A. Oliver Sartor, MD
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • Testicular, Penile & Rare GU Malignances
        • Testicular Cancer
      • Science in GU Oncology
        Bishoy M. Faltas, MD
    • Functional Urology
      • Functional Urology
        Alan J. Wein, MD, PhD (hon.)
      • Urologic Catheters - CAUTI Challenges
  • Videos
    • Exclusives
      • Conferences
      • Disparities: Social Determinants of Health
      • Exclusive Collaborations
      • Health Policy in Urological Diseases
      • Independent Medical Education
      • Journal Clubs
      • Practice Guidelines Reviews
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Functional Urology
      • Men's Health
      • Pelvic Health
  • Actionable Clinical Data
    • Bladder Cancer
      • NMIBC with CIS: Evidence, Practice & Emerging Research
      • Risk-Stratified NMIBC Management
  • Trials in Progress
    • Prostate Cancer
      • Localized Prostate Cancer
        • CLARIFY
        • ESCAPE
        • FORT
        • NRG-GU 0101
        • RTIRE
      • High Risk BCR HSPC
        • ARASTEP
      • Oligometastatic Prostate Cancer
        • METANOVA
      • mHSPC
        • ARASEC
        • ASPIRE
        • MEVPRO-3
      • mCRPC
        • ECLIPSE
        • LEGION-100
        • MEVPRO-1 & 2
        • PROMISE
        • SECuRE
    • Bladder Cancer
      • PIVOT-006
    • Kidney Cancer
      • RadiCal
      • SAMURAI
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • BCAN TT 2026
      • USPCC 2026
      • SNMMI 2026
      • ASCO 2026
      • AUA 2026
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Beyond the Abstracts
  3. Men's Health

BPH - Benign Prostatic Enlargement

Beyond the Abstracts
Quantifying Symptomatic Benefit in the Individual Patient: Lessons from an N-of-1 Tamsulosin Trial - Expert Commentary August 10, 2026
Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men: A Randomized Clinical Trial. August 10, 2026
The impact of prostate size on outcomes of aquablation: a prospective study. August 9, 2026
Surgical management of acquired bladder diverticula in adult men: a scoping review. August 3, 2026
Development of the Short Form of the Specific Module of QLICD-BPH (V2.0) for Assessing Quality of Life with Benign Prostatic Hyperplasia by Classical Test Theory, Item Response Theory, and Generalizability Theory. August 3, 2026
HoLEP for large and mega glands: real-world outcomes and evidence of size-enhanced efficiency. August 3, 2026
miR-143-3p integrates contractility and growth in benign prostate stromal cells. July 27, 2026
Within-Patient Association Between Improvement in Lower Urinary Tract Symptoms and Change in Sexual Function After Prostatic Artery Embolization. July 26, 2026
Fucoidan from Undaria pinnatifida Improves Benign Prostatic Hyperplasia Symptoms in Men: A Randomized, Double-Blind, Placebo-Controlled Study. July 26, 2026
Endoscopic Outlet Surgery versus Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders. July 20, 2026
Same-Day Discharge After GreenLight Laser Photoselective Vaporization of the Prostate in Patients With Moderate to Severe Lower Urinary Tract Symptoms. August 10, 2026
Clinical guidance and expert opinion on the use of prostatic urethral lift implants for benign prostatic hyperplasia. August 9, 2026
Long-term patterns of surgical reintervention after various benign prostatic hyperplasia procedures in a large national database. August 9, 2026
Decision regret and patient satisfaction after TURP and Rezūm™ for benign prostatic obstruction: a retrospective comparative cohort study. August 3, 2026
Preserving the Endoscopic Promise of HoLEP: A Standardized Technique for Safe and Efficient Morcellation Across Prostate Sizes. August 3, 2026
Preoperative Prostatic Artery Embolization Combined With Transurethral Resection of the Prostate Versus Transurethral Resection of the Prostate Alone in Large Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. July 27, 2026
Exercise and Physical Activity as Modifiable Risk Factors for Benign Prostatic Hyperplasia: An Update. July 26, 2026
Surgical Treatment Options for Geriatric Patients With Benign Prostatic Hyperplasia: Advocating for Early Transdisciplinary Geriatric Involvement and Minimally Invasive Surgical Options. July 26, 2026
Shaping the Future of Men's Health: How AI Could Be a Transformative Tool for Better Patient Outcomes and Provider Efficiency. July 26, 2026
Trends in rates and outcomes of benign prostatic hyperplasia surgeries: a retrospective cohort study using the ACS-NSQIP database (2008-2021). July 20, 2026
Page 1 of 171
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2026 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free